Alkermes Inc. plc
$43.39
-$3.32 (-7.11%)
$43.27Day Range$46.53
Key Statistics
Market Cap
$7.84B
Shares Outstanding
167.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 16, 1991
Round Lot
100
Locale
US
Trading Data
Day Open
$46.51
Day High
$46.53
Day Low
$43.27
Volume
6.94M
VWAP
$43.72
Prev Close
$46.71
Transactions
--
Acc. Volume
--
About Alkermes Inc. plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
PHARMACEUTICAL PREPARATIONSSIC 28342,050 employeesCONNAUGHT HOUSE, DUBLIN 4, L2, 0000000-353-1-772-8000IPO Jul 16, 1991US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001520262
- Ticker Root
- ALKS
- SIC Code
- 2834
About Alkermes Inc. plc (ALKS) Stock
Alkermes Inc. plc (ALKS) closed the 2026-09-18 session at $43.39, down 7.11% versus the previous close (-3.32). The stock opened at $46.51 and traded between $43.27 and $46.53 during that session. Session trading volume was 6.9M shares. The volume-weighted average price (VWAP) is $43.72.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Alkermes Inc. plc has a market capitalization of $7.84 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ALKS is listed on the XNAS exchange. The company employs approximately 2,050 people. Alkermes Inc. plc is headquartered in DUBLIN 4, L2. The recorded listing date is 1991-07-16.
On this page you can find market ALKS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.